At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ABVX Abivax S.A.
Market Closed 10-30 16:00:00 EDT
86.59
-2.47
-2.77%
盘后87.03
+0.44+0.51%
19:40 EDT
High88.90Low85.81Vol843.01K
Open87.66D1 Closing89.06Amplitude3.47%
Mkt Cap7.58BTradable Cap6.16BTotal Shares87.54M
T/O73.38MT/O Rate1.19%Tradable Shares71.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Movement Alert｜Abivax S.A. Falls 5.07% in Regular Trading, Target Price Cut Weighs on Sentiment
Market Focus  ·  10-23
Movement Alert｜Abivax S.A. Falls 5.07% in Regular Trading, Target Price Cut Weighs on Sentiment
Abivax Sa : Wedbush Cuts Target Price to $96 from $118
THOMSON REUTERS  ·  10-21
Abivax Sa : Wedbush Cuts Target Price to $96 from $118
US Research Roundup-Eli Lilly, Netflix, Zscaler
Reuters  ·  10-21
US Research Roundup-Eli Lilly, Netflix, Zscaler
Movement Alert｜Abivax S.A. Intraday Rise 5.2% in Regular Trading, Focus Remains on Pipeline Value After Target Price Cut
Market Focus  ·  10-20
Movement Alert｜Abivax S.A. Intraday Rise 5.2% in Regular Trading, Focus Remains on Pipeline Value After Target Price Cut
Wedbush Adjusts Price Target on Abivax to $96 From $118, Keeps Neutral Rating
MT Newswires Live  ·  10-20
Wedbush Adjusts Price Target on Abivax to $96 From $118, Keeps Neutral Rating
Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  10-20
Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)
Movement Alert｜Abivax S.A. Falls 5.85% in Pre-Market Trading, H1 miss and target-price cuts remain an overhang
Market Focus  ·  10-19
Movement Alert｜Abivax S.A. Falls 5.85% in Pre-Market Trading, H1 miss and target-price cuts remain an overhang
Movement Alert｜Abivax S.A. Falls 5.07% in Regular Trading, H1 miss and target cuts remain an overhang
Market Focus  ·  10-17
Movement Alert｜Abivax S.A. Falls 5.07% in Regular Trading, H1 miss and target cuts remain an overhang
Movement Alert｜Abivax S.A. Intraday Rise 5.01% in Regular Trading, rebound follows fading impact of post-H1 target price cuts
Market Focus  ·  10-15
Movement Alert｜Abivax S.A. Intraday Rise 5.01% in Regular Trading, rebound follows fading impact of post-H1 target price cuts
Movement Alert｜Abivax S.A. Falls 5.18% in Regular Trading, Earnings Miss and Analyst Downgrades Weigh on Shares
Market Focus  ·  10-01
Movement Alert｜Abivax S.A. Falls 5.18% in Regular Trading, Earnings Miss and Analyst Downgrades Weigh on Shares
Movement Alert｜Abivax S.A. Rises 5.1% in Regular Trading, Trading at $95.33
Market Focus  ·  09-28
Movement Alert｜Abivax S.A. Rises 5.1% in Regular Trading, Trading at $95.33
Movement Alert｜Abivax S.A. Falls 5.28% in Regular Trading, Continued Selling Pressure After H1 EPS Missed Estimates by 125%
Market Focus  ·  09-24
Movement Alert｜Abivax S.A. Falls 5.28% in Regular Trading, Continued Selling Pressure After H1 EPS Missed Estimates by 125%
Movement Alert｜Abivax S.A. Falls 5.47% in Regular Trading, H1 EPS Misses Estimates as Analysts Slash Price Targets
Market Focus  ·  09-22
Movement Alert｜Abivax S.A. Falls 5.47% in Regular Trading, H1 EPS Misses Estimates as Analysts Slash Price Targets
These Analysts Slash Their Forecasts On Abivax Following H1 Results
Benzinga Earnings  ·  09-22
These Analysts Slash Their Forecasts On Abivax Following H1 Results
Abivax price target lowered to $151 from $155 at Truist
TIPRANKS  ·  09-22
Abivax price target lowered to $151 from $155 at Truist
Abivax Sa : Truist Securities Cuts Target Price to $151 from $155
THOMSON REUTERS  ·  09-22
Abivax Sa : Truist Securities Cuts Target Price to $151 from $155
Wedbush Cuts Price Target on Abivax to $118 From $160, Keeps Neutral Rating
MT Newswires Live  ·  09-22
Wedbush Cuts Price Target on Abivax to $118 From $160, Keeps Neutral Rating
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)
TIPRANKS  ·  09-22
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)
US Research Roundup-Boeing, Twilio, WP Carey
Reuters  ·  09-22
US Research Roundup-Boeing, Twilio, WP Carey
Abivax SA Reports Results for the Quarter Ended March 31 - Earnings Summary
Reuters  ·  09-22
Abivax SA Reports Results for the Quarter Ended March 31 - Earnings Summary

Introduction

Company Name.
Abivax S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Issue price:
--